Venture Global: $13.8B Revenue at Peak Commissioning, but EBITDA Guides Down 15%
Five major oil companies filed arbitration over the 37-month commissioning period. Every insider sold to zero. And 2026 earnings guidance is lower than 2025 actuals. Our 5-lens committee dissects what the numbers mean.
Tripled YoY, driven by commissioning cargoes
Down from $6.3B actual in FY2025
Up $10B in one year
20-year SPAs across ~49 MTPA
Venture Global went public in January 2025 and immediately posted one of the most impressive revenue growth stories in energy: $13.8 billion in FY2025 revenue, tripling from $5 billion the year before. EBITDA reached $6.3 billion. The company simultaneously constructs 57+ MTPA of LNG capacity across multiple Gulf Coast facilities while operating Calcasieu Pass, which finally reached commercial operations in April 2025 after a 37-month commissioning period.
That commissioning period is the central tension in the VG story. Five major oil companies filed arbitration proceedings alleging VG deliberately delayed declaring commercial operations to sell LNG at spot prices of $6-8/MMBtu instead of honoring contracted SPA rates of roughly $2/MMBtu. Two panels found no liability. One found partial liability. And the FY2026 EBITDA guidance of $5.2-5.8 billion reveals what happens when commissioning revenue gives way to contracted rates.
We ran VG through five analytical lenses using an Opus and Sonnet ensemble with adversarial discourse. The picture that emerges is layered: a genuinely massive business with proven economics and $134 billion in contracted revenue, but one whose IPO-era financials are inflated by temporary commissioning dynamics.
Want the full 5-lens analysis with signal assessments and model debates?
Opus + Sonnet ensemble. 5 lenses. 8 signals. 5 debates. Full evidence citations.
Signal Assessments
FY2025 revenue inflated by commissioning cargoes at 3-4x SPA rates. 37-month CP1 commissioning challenged by five counterparties.
Every insider exercised pre-IPO options and sold to zero retention. No open market purchases. Founders retain 100% project ownership but hold zero stock.
$53B in assets, $33B raised in 2025, $15B+ project finance per project. Ring-fencing is theoretical given $3.3B Plaquemines equity injection.
100% ownership maximizes returns but concentrates all risk. $3.3B budget overrun absorbed, but pattern could repeat at CP2.
Critical FERC and DOE permits secured. Political environment strongly supportive. Arbitration outcomes are the primary regulatory-adjacent risk.
$134B contracted base is genuinely durable, but current revenue levels inflated by commissioning. A 2-3 year vulnerability window exists.
CP1 demonstrates profitable operations at SPA rates. Physical commodity business with genuine demand. CP2 projected at >30% project ROE.
At ~9-10x forward EBITDA, the stock requires flawless execution on Plaquemines COD, CP2 construction, and bolt-on expansions.
Key Findings
Commissioning Revenue Is the Whole Story
FY2025's $13.8B revenue was dominated by LNG sold during commissioning at $6-7/MMBtu. Post-COD SPA rates are $1.76-2.14/MMBtu, a 60-70% per-cargo revenue decline. The FY2026 EBITDA guidance of $5.2-5.8B (vs. $6.3B in FY2025) confirms this transition. Each new facility repeats the cycle: high-margin commissioning followed by a step-down to contracted rates.
37-Month Commissioning Period: Five Counterparties Disagree
Calcasieu Pass shipped its first cargo in March 2022 but did not reach commercial operations until April 2025. Five major oil companies filed arbitration alleging deliberate delay. The outcomes are mixed: Shell and Repsol found no liability, BP received a partial adverse finding with no damages set, and four arbitrations remain pending with an aggregate liability cap of $765M.
In VG's Favor
- • Shell arbitration: no liability
- • Repsol arbitration: no liability (January 2026)
- • Revenue recognition technically GAAP compliant
- • Operational complexity partially explains timeline
Against VG
- • BP partial adverse finding
- • 37 months exceeds industry commissioning norms
- • Enormous financial incentive to delay COD
- • $4.8B-$5.5B in total remedies sought
$3.3B Plaquemines Overrun: Proactive or Problematic?
VG injected $3.3 billion of additional equity into Plaquemines beyond the FID budget. Management frames this as proactive investment in temporary power and other scopes. Our committee sees it both ways: the willingness to invest demonstrates commitment to execution, but a 20-30% cost escalation establishes a pattern that may repeat at CP2.
Insider Selling to Zero: Where Is the Alignment?
Every significant insider exercised pre-IPO options at $1.16/share and sold all resulting shares at $13-16/share. CFO Thayer netted ~$46M, Larson ~$71M. After exercises, every insider holds zero shares. Our committee noted a critical nuance: while stock-level alignment is absent, founders retain 100% ownership of Plaquemines and CP2 through project entities.
Where Models Disagreed
How Severe Is the Accounting Concern?
Opus Position
QUESTIONABLE: Revenue recognition is technically GAAP compliant, and two arbitration panels found no liability. The commissioning period is long but partially explained by operational complexity.
Sonnet Position
Initially rated CONCERNING: the substance of extended commissioning at spot prices overwhelms technical compliance. The financial incentive to delay was enormous.
Resolution
Converged on QUESTIONABLE after acknowledging that two independent panels found no liability, reducing the severity of the deliberate delay theory.
100% Ownership: Visionary or Reckless?
Adopted
MIXED: The strategy is coherent and potentially value-maximizing. If VG reaches $11B-$17B EBITDA by 2029 with 100% ownership, returns would be extraordinary.
Withdrawn
Sonnet's initial QUESTIONABLE rating was withdrawn after recognizing that the Plaquemines overrun was handled without parent-level capital raises.
Cross-Lens Reinforcements
Revenue quality is the central concern
Three lenses independently concluded FY2025 revenue overstates recurring earnings power due to commissioning at 3-4x SPA rates.
The underlying business is real and durable
All lenses agree VG operates a genuine physical commodity business with proven unit economics and $134B in contracted revenue.
Regulatory risk is manageable
VG is not a regulatory arbitrage play. Key FERC and DOE permits are secured. The political environment strongly supports LNG exports.
Execution risk is the binding constraint
Every lens identifies construction execution as the key variable. The $3.3B Plaquemines overrun validates the concern.
What to Watch
Not scheduled yet; expected 2027. The only uncapped arbitration. A large damages award could cascade into remaining cases and force reserve revisions.
On schedule for Q4 2026. Delays beyond Q1 2027 would extend the commissioning period and push out the revenue transition timeline.
Guided at $5.2B-$5.8B. Below $5.0B signals execution problems. Above $6.0B may indicate extended commissioning or strong commodity prices.
Expected “in coming weeks” as of March 2026. Demonstrates continued lender confidence and management's ability to finance growth without parent-level capital raises.
Currently zero stock retention across all insiders. Any open market purchase by senior management would be a strong positive governance signal.
HIGHER SCRUTINY
Venture Global operates a genuine, massive LNG business with proven economics and $134B in contracted revenue. The underlying assets will produce LNG for decades, and the long-term growth trajectory is compelling. However, FY2025 financials are inflated by temporary commissioning revenue, governance alignment mechanisms are absent at the stock level, and the 2-3 year transition window creates a period of elevated uncertainty.
Path to More Favorable Assessment
- • Plaquemines COD on schedule (Q4 2026)
- • CP2 Phase 2 FID completed
- • Remaining arbitrations resolved favorably
- • Any insider open market share purchase
- • FY2026 EBITDA at or above guidance range
Path to Less Favorable Assessment
- • BP damages exceeding $2B
- • Plaquemines COD delayed beyond Q1 2027
- • CP2 budget overruns exceeding $2B
- • Parent-level equity or debt raise
- • Sustained TTF spread below $3/MMBtu
This analysis is for educational purposes only — it is not a recommendation to buy or sell any security.
Public Sources Used (12 documents)
- • Annual Report (10-K) — FY2025
- • Quarterly Reports (10-Q) — Q1, Q2, Q3 2025
- • IPO Prospectus (S-1) — December 2024
- • Proxy Statement (DEFA14A) — April 2025
- • Current Reports (8-K) — 10 filings, 2025-2026
- • Q4 2025 Earnings Call Transcript
- • Q3 2025 Earnings Call Transcript
- • Q1 2025 Earnings Call Transcript
- • Form 4 Insider Transaction Filings (20 filings)
- • Form 144 Proposed Sale Notices (10 filings)
Full Analysis with Signal Breakdowns
Explore the complete 5-lens assessment including debate transcripts, evidence citations, and monitoring triggers for Venture Global.
View VG Analysis